<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7-vaccines-07-00203">
 <label>7.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lescar</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sampath</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Canard</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Vasudevan</surname>
    <given-names>S.G.</given-names>
   </name>
  </person-group>
  <article-title>Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target</article-title>
  <source>Antiviral Res.</source>
  <year>2008</year>
  <volume>80</volume>
  <fpage>94</fpage>
  <lpage>101</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2008.07.001</pub-id>
  <pub-id pub-id-type="pmid">18674567</pub-id>
 </element-citation>
</ref>
